Taking 12 mg of cafestol daily for 12 weeks does not raise bad cholesterol (LDL) in people with excess belly fat, which contradicts earlier findings that cafestol increases LDL, suggesting the effect may depend on dose or individual factors.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether cafestol’s effect on LDL cholesterol is dose-dependent and whether 12 mg/day is below the threshold for elevation across populations.
A systematic review and meta-analysis of all RCTs measuring LDL changes after cafestol supplementation (doses 5–50 mg/day) for ≥4 weeks, pooling standardized mean differences and modeling dose-response curves with subgroup analyses by baseline LDL and coffee habits.
Whether 12 mg/day cafestol consistently fails to raise LDL across diverse populations, and whether higher doses (e.g., 20–30 mg) trigger elevation.
A double-blind RCT with 100 participants aged 30–70, randomized to 5 mg, 12 mg, 20 mg, or placebo cafestol daily for 12 weeks, with fasting LDL measured at baseline, 4, 8, and 12 weeks, and lipid profile adjusted for baseline levels and sex.
Whether habitual consumption of unfiltered coffee (high cafestol) is associated with higher LDL levels over time compared to filtered coffee.
A prospective cohort of 5,000 adults followed for 10 years, with annual LDL measurements and detailed coffee consumption logs (brewing method, frequency, volume), adjusting for diet, statin use, and genetics.
Whether individuals with elevated LDL have higher historical cafestol exposure than those with normal LDL.
A case-control study comparing 200 adults with LDL >160 mg/dL to 200 with LDL <100 mg/dL, matched for age, sex, and BMI, using dietary recall and biomarkers to estimate lifetime cafestol intake from unfiltered coffee.
Whether current unfiltered coffee intake correlates with LDL levels in a population sample.
A cross-sectional survey of 3,500 adults measuring daily unfiltered coffee intake and fasting LDL, adjusting for age, sex, BMI, statin use, and dietary saturated fat intake.